Molecular drivers of metastatic disease in breast cancer

At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, explains that genetic differences between primary and metastatic breast cancer may have important clinical implications, including for the identification of biomarkers for disease progression.

Year of Production:
Running Time:
Color/Sound:

2015
01:16
Color/Sound

Comments are closed.